OnCore Login

Return to Trial Database

HCRN-LUN14-179

A Phase II Trial of Concurrent Chemoradiation With Consolidation Pembrolizumab (MK-3475) for the Treatment of Inoperable or Unresectable Stage III Non-Small Cell Lung Cancer (NSCLC): HCRN LUN14-179

Status

Study Completed

Cancer Type(s)

Lung

Study Contact

Publications

The association between immune-related adverse events and efficacy outcomes with consolidation pembrolizumab after chemoradiation in patients with stage III NSCLC
  • N Shukla, SK Althouse, AA Sadiq, SI Jalal, SK Jabbour, R Zon, GH Kloecker, WB Fisher, KL Reckamp, EA Kio, RM Langdon, B Adesunloye, RD Gentzler, NH Hanna, GA Durm
P1.18-05 ChemoXRT w/ Consolidation Pembrolizumab in Unresectable Stage III NSCLC: Long-Term Survival Update and Analysis of Post-Progression Therapy
  • G Durm, S Althouse, A Sadiq, S Jalal, S Jabbour, R Zon, G Kloecker, M Williamson, K Reckamp, E Kio, R Langdon, B Adesunloye, R Gentzler, W Harb, R Walling, C Yeon, M Koczywas, N Hanna
Phase II trial of concurrent chemoradiation with consolidation pembrolizumab in patients with unresectable stage III non-small cell lung cancer
  • GA Durm, SK Althouse, AA Sadiq, SI Jalal, S Jabbour, R Zon, GH Kloecker, WB Fisher, KL Reckamp, EA Kio, RM Langdon, B Adesunloye, RD Gentzler, NH Hanna
Phase II trial of consolidation Pembrolizumab following concurrent chemoradiation in patients (pts) with unresectable or inoperable stage III non-small cell lung cancer (NSCLC): initial safety data from HCRN LUN12-179
  • GA Durm, EA Kio, WB Fisher, ML Titzer, S Jabbour, T Breen, Z Liu, NH Hanna
A phase 2 trial of consolidation pembrolizumab following concurrent chemoradiation for patients with unresectable stage III non–small cell lung cancer
  • GA Durm, SK Jabbour, SK Althouse, Z Liu, AA Sadiq, RT Zon, SI Jalal, GH Kloecker, MJ Williamson, KL Reckamp, RM Langdon, EA Kio, RD Gentzler, BA Adesunloye, WA Harb, RV Walling, ML Titzer, NH Hanna
Prognostic Variables Associated With Improved Outcomes in Patients With Stage III NSCLC Treated With Chemoradiation Followed by Consolidation Pembrolizumab: A Subset Analysis of a Phase II Study
  • B Anouti, S Althouse, G Durm, N Hanna
Potential Predictors of Pembrolizumab Associated Pneumonitis: A Retrospective Review of the HCRN LUN 14-179 Trial
  • SS Ahmed, GA Durm, J Donatelli, Y Liu, H Yao, C Desrosiers, Z Liu, FM Kong, N Hanna

Trial Locations

All sites in which the trial HCRN-LUN14-179 being conducted in.
No data was found
  • 7676 Interactive Way, Suite 120, Indianapolis, IN 46278